13th Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) for prequalification
The following active pharmaceutical ingredients (APIs) were added:
- Azithromycin
- Miltefosine
- Paromomycin
- Sodium stibogluconate (SB5+)
TB336: Rifapentine - 150mg - Film-coated tablets - Sanofi-Aventis U.S. LLC - USA
Miltefosine 10mg and 50mg capsule
The revisions to the BTIF (Bioequivalence Trial Information Form) include the following changes to facilitate study assessment:
The Medicines Patent Pool today announced that it has signed a licence w
Treatment of maternal syphilis and prevention of congenital syphilis
Adult formulations
Medroxyprogesterone manufactured by Taizhou Taifa Pharmaceutical Co Ltd has been prequalified by the WHO Prequalification Team: medicines (PQTm) under its API prequalification procedure.
New addition to the List of Prequalified Quality Control Laboratories (QCL):
WHO Prequalification Team - Medicines (PQT) added the below new products to its prequalified list
Cycloserine manufactured by Zhejiang Hisun Pharmaceutical Co Ltd and Zinc (sulfate) manufactured by Canton Laboratories Pvt Ltd have been prequalified by the WHO Prequalification Team: medicines (P
DI005: Zinc (as sulfate monohydrate) - 20mg - Dispersible tablets - Macleods Pharmaceuticals Ltd - INDIA
Dihydroartemisinin manufactured by Ipca Laboratories Ltd has been prequalified by the WHO Prequalification Team: medicines (PQTm) under its API prequalification procedure.
WHO Prequalification Team - Medicines (PQT) adds the below new products to its prequalified list
WHO Prequalification Team - Medicines (PQT) adds the below new products to its prequalified list
The 11th invitation to manufacturers of active pharmaceutical ingredients (APIs) to submit an expression of interest (EOI) for API prequalification to the WHO Prequalification Team: medicines (PQTm
The following products were added to the EOI:
WHO Prequalification Team - Medicines (PQT) added the below new product to its prequalified list:
Levofloxacin manufactured by Shangyu Jingxin Pharmaceutical Co Ltd has been prequalified by the WHO Prequalification Team: medicines (PQTm) under its API prequalification procedure.
WHO Prequalification Team - Medicines (PQT) added the below new products to its prequalified list
WHO Prequalification Team - Medicines (PQT) added the below new product to its prequalified list:
Lumefantrine manufactured by Micro Labs Ltd and Lopinavir manufactured by Acebright (India) Pharma Pvt Ltd have been prequalified by the WHO Prequalification Team: medicines (PQTm) under its API pr
WHO Prequalification Team - Medicines (PQT) added the below new products to its prequalified list
Visit the WHO website for updates on patent information on treatments for Hepatitis C
The lack of prequalified reproductive health medicines is of great concern to WHO and to partner organizations working to improve reproductive health.
To assist manufacturers in resource-limited countries who are keen to attain product prequalification, WHO-PQT is initiating a pilot collaboration whereby manufacturers can requ
WHO Prequalification Team - Medicines (PQTm) added the below new products to its prequalified list
WHO Prequalification Team - Medicines (PQT) added the below new product to its prequalified list